CompletedNo phase
Transjugular Intrahepatic Portosystemic Shunts Improve Survival in Patients With Cirrhosis and Recurrent Ascites
Key facts
- Who runs it
- Tang-Du Hospital
- Where
- China3 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 462 people enrolled
- Started
- 1 Dec 2023
- Ended
- 1 Feb 2024
- Type of study
- Observational, 2 groups
- Treatments tested
- transjugular intrahepatic portal shunt
- Record updated
- 27 August 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Definite diagnosis of recurrent ascites in cirrhosis (based on clinical symptoms, laboratory and imaging studies, or liver biopsy) TIPS or LVP+A therapy, -
Who cannot take part
- Malignant neoplasm, including hepatocellular carcinoma with extrahepatic metastasis Prior liver transplantation Severe heart and lung dysfunction Recurrent hepatic encephalopathy Concomitant active infection TIPS with the use of uncovered stents Complete portal vein thrombosis
- -
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Currently, there is limited evidence regarding the survival benefit of early transjugular intrahepatic portal shunt (TIPS) placement in patients with cirrhosis and recurrent ascites. This observational study aimed to assess whether early TIPS improves the survival of patients with advanced cirrhosis and recurrent ascites. We will compare large volume paracenteses plus albumin (LVP+A） to see if TIPS improves the survival of patients with advanced cirrhosis and recurrent ascites.
The 2 groups in the trial
- TIPS
transjugular intrahepatic portal shunt
Treatment: transjugular intrahepatic portal shunt
- LVP+A
large volume paracenteses plus albumin
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- TIPS Improve Survival in Patients With Cirrhosis and Recurrent Ascites: a Multicenter Observational Study
- Record updated
- 27 August 2024